KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Shares Outstanding (Weighted Average) (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $27.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 3.37% to $27.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $27.3 million, a 3.37% decrease, with the full-year FY2025 number at $27.3 million, down 3.37% from a year prior.
  • Shares Outstanding (Weighted Average) was $27.3 million for Q4 2025 at Bio-Rad Laboratories, roughly flat from $27.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $29.9 million in Q1 2022 to a low of $27.2 million in Q2 2025.
  • A 5-year average of $28.9 million and a median of $29.4 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): grew 0.38% in 2021, then dropped 4.77% in 2024.
  • Bio-Rad Laboratories' Shares Outstanding (Weighted Average) stood at $29.8 million in 2021, then dropped by 0.15% to $29.8 million in 2022, then decreased by 1.93% to $29.2 million in 2023, then decreased by 3.41% to $28.2 million in 2024, then fell by 3.37% to $27.3 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Shares Outstanding (Weighted Average) are $27.3 million (Q4 2025), $27.4 million (Q3 2025), and $27.2 million (Q2 2025).